MAPT and Alzheimer disease: has been associated with an increased incidence of AD (Nemergut et al., 2022), possibly due to the activation of neuroinflammation in the hippocampus following alveolar bone resorption, which subsequently promotes Tau hyperphosphorylation in mice (Tang et al., 2022).